FIRST IN THE BALTICS: NORTHWAY BIOTECH OPENS €61 MILLION CELL THERAPY AND PERSONALIZED MEDICINE CDMO IN VILNIUS
Building on more than 22 years of CDMO experience across biologics and advanced therapies, Northway Biotech is significantly expanding its development and manufacturing capacity with a new 3,500 sq. m facility featuring up to 20 independent cGMP manufacturing lines and first customer...
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Envision Energy продвигает ветроэнергетический рынок Юго-Восточной Европы, поскольку крупнейший ветроэнергетический проект Северной Македонии достигает финансового закрытия
- Casio s'apprête à lancer une montre en édition limitée pour célébrer le 30e anniversaire de la gamme MR-G
- Shanghai Electric präsentiert drei Lösungen für die Energiewende auf der Enlit Asia 2026
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →